Insmed | Fremdkapital



Loan Capital Veränderung Datum
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Cytokinetics USD 713.04M 67.88M 2025-06
DBV Technologies USD 0 0 2025-03
Dynavax Technologies USD 220.75M 39.75M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
Insmed USD 560.95M 567.39M 2025-06
Novartis USD 22.93B 2.41B 2024-12
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Insmed Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.